Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Stryker Buys Trauson, a China Orthopedic Company, for $764 Million

publication date: Jan 17, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Stryker Corporation, a US medical device maker, will acquire a China orthopedic company, Trauson Holdings, for $764 million in cash. Trauson’s major shareholder, Luna Group with 62% of the outstanding shares, has agreed to the offer. Trauson makes orthopedic products for trauma and spine fixation. It has been manufacturing instrumentation sets for Stryker under an OEM agreement since 2007. More details....

Stock Symbols: (NYSE: SYK) (HK: 0325)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at this event:
 
 
Hope to see you there!
 
ChinaBio® Events
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors